Literature DB >> 11432996

Local response of L-type Ca(2+) current to nitric oxide in frog ventricular myocytes.

M Dittrich1, J Jurevicius, M Georget, F Rochais, B Fleischmann, J Hescheler, R Fischmeister.   

Abstract

1. The regulation of L-type Ca(2+) current (I(Ca)) by the two nitric oxide (NO) donors sodium nitroprusside (SNP, 1 microM to 1 mM) and (+/-)-S-nitroso-N-acetylpenicillamine (SNAP, 3 or 10 microM) was investigated in frog ventricular myocytes using double voltage clamp and double-barrelled microperfusion techniques. 2. SNP and SNAP depressed the isoprenaline (ISO, 10-100 nM)- or forskolin (FSK, 1 microM)-mediated stimulation of I(Ca) via cGMP activation of the cGMP-stimulated phosphodiesterase (PDE2). Complete inhibition of the ISO (100 nM) response was observed at 1 mM SNP. 3. When SNP was applied locally, i.e. to one-half of the cell, and ISO to the whole cell, the response of I(Ca) to ISO was strongly antagonized in the cell half exposed to SNP (up to 100 % inhibition at 1 mM SNP) but a relatively small depression was observed in the other half of the cell (only 20 % inhibition at 1 mM SNP). 4. The NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (carboxy-PTIO, 1 mM) reversed the local effect of SNAP (3 microM) on FSK-stimulated I(Ca) when applied to the same side as the NO donor, but had no effect when applied to the other side of the cell. 5. A local application of erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, 30 microM), a selective inhibitor of PDE2, fully reversed the local effect of SNP (100 microM) or SNAP (10 microM) on I(Ca) but had no effect on the distant response. 6. When EHNA was applied on the distant side, with SNP (1 mM) and ISO (100 nM) applied locally, the distant effect of SNP was fully reversed. 7. Our results demonstrate that in frog ventricular myocytes stimulation of guanylyl cyclase by NO leads to a strong local depletion of cAMP near the L-type Ca(2+) channels due to activation of PDE2, but only to a modest reduction of cAMP in the rest of the cell. This may be explained by the existence of a tight microdomain between L-type Ca(2+) channels and PDE2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432996      PMCID: PMC2278687          DOI: 10.1111/j.1469-7793.2001.00109.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  48 in total

Review 1.  Hormonal control of cardiac ion channels and transporters.

Authors:  Y Shimoni
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

Review 2.  A new nitric oxide scavenger, imidazolineoxyl N-oxide derivative, and its effects in pathophysiology and microbiology.

Authors:  H Maeda; T Akaike; M Yoshida; K Sato; Y Noguchi
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

Review 3.  Sodium nitroprusside: twenty years and counting.

Authors:  J A Friederich; J F Butterworth
Journal:  Anesth Analg       Date:  1995-07       Impact factor: 5.108

Review 4.  Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.

Authors:  V C Manganiello; T Murata; M Taira; P Belfrage; E Degerman
Journal:  Arch Biochem Biophys       Date:  1995-09-10       Impact factor: 4.013

5.  Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.

Authors:  H H Valdivia; J H Kaplan; G C Ellis-Davies; W J Lederer
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

6.  cGMP-dependent protein kinase regulation of the L-type Ca2+ current in rat ventricular myocytes.

Authors:  K Sumii; N Sperelakis
Journal:  Circ Res       Date:  1995-10       Impact factor: 17.367

7.  cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists.

Authors:  J Jurevicius; R Fischmeister
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

8.  Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle.

Authors:  J Hain; H Onoue; M Mayrleitner; S Fleischer; H Schindler
Journal:  J Biol Chem       Date:  1995-02-03       Impact factor: 5.157

9.  Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.

Authors:  P F Méry; C Pavoine; F Pecker; R Fischmeister
Journal:  Mol Pharmacol       Date:  1995-07       Impact factor: 4.436

10.  Nitric oxide regulates the calcium current in isolated human atrial myocytes.

Authors:  M Kirstein; M Rivet-Bastide; S Hatem; A Bénardeau; J J Mercadier; R Fischmeister
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  18 in total

Review 1.  Clinical and molecular genetics of the phosphodiesterases (PDEs).

Authors:  Monalisa F Azevedo; Fabio R Faucz; Eirini Bimpaki; Anelia Horvath; Isaac Levy; Rodrigo B de Alexandre; Faiyaz Ahmad; Vincent Manganiello; Constantine A Stratakis
Journal:  Endocr Rev       Date:  2013-12-05       Impact factor: 19.871

Review 2.  Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart.

Authors:  Chen Yan; Clint L Miller; Jun-ichi Abe
Journal:  Circ Res       Date:  2007-03-02       Impact factor: 17.367

3.  Phenylephrine acts via IP3-dependent intracellular NO release to stimulate L-type Ca2+ current in cat atrial myocytes.

Authors:  Y G Wang; E N Dedkova; X Ji; L A Blatter; S L Lipsius
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

Review 4.  Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.

Authors:  Clint L Miller; Chen Yan
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

5.  Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.

Authors:  Liliana R V Castro; Ignacio Verde; Dermot M F Cooper; Rodolphe Fischmeister
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

6.  A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.

Authors:  Matthijs L Becker; Loes E Visser; Christopher Newton-Cheh; Albert Hofman; André G Uitterlinden; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

Review 7.  Therapeutic potential of PDE modulation in treating heart disease.

Authors:  Walter Knight; Chen Yan
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

8.  Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.

Authors:  Jonas Jurevicius; V Arvydas Skeberdis; Rodolphe Fischmeister
Journal:  J Physiol       Date:  2003-06-18       Impact factor: 5.182

Review 9.  Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.

Authors:  W E Knight; C Yan
Journal:  Horm Metab Res       Date:  2012-09-05       Impact factor: 2.936

10.  Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes.

Authors:  Elena N Dedkova; Yong Gao Wang; Lothar A Blatter; Stephen L Lipsius
Journal:  J Physiol       Date:  2002-08-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.